Sequence information
Variant position: 1235 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1480 The length of the canonical sequence.
Location on the sequence:
LTAKYTEGGNAILENISFSI
S PGQRVGLLGRTGSGKSTLLS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LTAKYTEGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
Gorilla LTAKYTEGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
LTAKYIDGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
Rhesus macaque LTAKYTEGGNPILENISFSIS PGQRVGLLGRTGSGKSTLLS
Chimpanzee LTAKYTEGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
Mouse LTVKYMDDGNAVLENISFSIS PGQRVGLLGRTGSGKSTLLS
Rat LTVKYVDDGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
Pig LTAKYVDGGNAVLENISFSIS PGQRVGLLGRTGSGKSTLLL
Bovine LTAKYTDGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLL
Rabbit LTAKYIDSGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
Sheep LTAKYIDGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLL
Horse LTAKYTDGGNAILENISFSIS PGQRVGLLGRTGSGKSTLLS
Xenopus laevis LSANYIDGGNTVLENISFSLS PGQRVGLLGRTGSGKSTLLS
Zebrafish LTVKYTEAGHAVLKNLSFSAE GRQRVGILGRTGSGKSSLFN
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1480
Cystic fibrosis transmembrane conductance regulator
Topological domain
1152 – 1480
Cytoplasmic
Domain
1210 – 1443
ABC transporter 2
Binding site
1219 – 1219
ATP 2
Alternative sequence
606 – 1480
Missing. In isoform 3.
Mutagenesis
1250 – 1250
K -> M. No effect on maturation of glycans, suggesting that trafficking to the plasma membrane is not altered.
Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.